resorcinol has been researched along with Breast Cancer in 3 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Excerpt | Relevance | Reference |
---|---|---|
"ERBB2-positive patients with breast cancer are exquisitely sensitive to Hsp90 inhibition." | 2.48 | Molecular pathways: targeting hsp90--who benefits and who does not. ( Cortes, J; Dawood, S; Scaltriti, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Yang, X | 1 |
Zhao, Z | 1 |
Zhao, C | 1 |
Li, Y | 1 |
El-Kott, AF | 1 |
Bani-Fwaz, MZ | 1 |
Scaltriti, M | 1 |
Dawood, S | 1 |
Cortes, J | 1 |
Pecegueiro, M | 1 |
1 review available for resorcinol and Breast Cancer
Article | Year |
---|---|
Molecular pathways: targeting hsp90--who benefits and who does not.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Breast Neoplasms; Cell Proliferation; | 2012 |
2 other studies available for resorcinol and Breast Cancer
Article | Year |
---|---|
Anti-breast Adenocarcinoma and Anti-urease Anti-tyrosinase Properties of 5-Pentylresorcinol as Natural Compound with Molecular Docking Studies.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Humans; Molecular Docking Simulation; Monophenol Monooxyge | 2022 |
Contact dermatitis due to resorcinol in a radiotherapy dye.
Topics: Adult; Breast Neoplasms; Dermatitis, Contact; Female; Humans; Resorcinols; Rosaniline Dyes | 1992 |